COVID-19: Canadian manufacturer Medicago says its vaccine shows promise in trials
CA, 08 Dec 2021
Although the data still needs to be scrutinized, Quebec company Medicago says its latest trial suggests the COVID-19 vaccine it's produced with GlaxoSmithKline is showing promise.
Their phase 3 clinical trial found the two-dose vaccine to be 71 per cent effective against most variants of COVID-19.
However, Omicron was not included as the variant wasn't known about when the trial was conducted.
Jamie Mauracher explains where the Canadian-made shot is now in the approval process and why it could help fight the pandemic beyond Canada.
For more info, please go to https://globalnews.ca/news/8430579/canadian-manufacturer-medicagos-covid-19-vaccine/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #Medicago #COVID-19Vaccine